Searched for
KIRAN SOMVANSHI
Our new name, IIM-Mumbai, will give us new focus, new attention: NITIE director Manoj TiwariLast week, the National Institute of Industrial Engineering (NITIE) became the country’s 21st Indian Institute of Management (IIM), and Mum...- 'We are committed to source our ingredients from green chemistry'There is not one single company that can afford today to not rethink its business model. From an environmental, economic, and social perspe...
- Patanjali: Indian FMCG's new BaahubaliThe Baba Ramdev-led company clocked revenue of Rs 10,561 crore in FY17, making it the second-largest pure-play FMCG player after market lea...
- ITC and Hindustan Unilever may not be on same FMCG street in Q2ITC's cigarette volumes is estimated to increase by 3% whereas HUL is likely to post volume growth in the range of 2-3%.
- Eight tips on how not to investInvesting requires being alert about the state of your investments and calls for active participation — a feat which not many can achieve.
- Maggi’s gaining, but Nestle has its set of woesThe stock had gained nearly 30% in the second quarter. It was just 1.5% short of breaching its record high of Rs 7,499.
- Why retail investors typically don’t make money on the StreetMost retail investors, with small investment and lack of patience, often exit from stocks (even if these are blue chips) due to panic when ...
- Sun Pharma shares fall 6% despite company's strong Q4 showConsolidated revenues for the quarter grew 21% — thanks to the two months of exclusivity period sales of generic drug Gleevec.
- Six things to watch out for in Hindustan Unilever’s Q4 resultsHUL is likely to post volume growth of 6% for the fifth consecutive quarter amid subdued demand and insignificant recovery.
- Biocon, Piramal & GSK buck the pharma trend, outperform amid absence of FDA issuesWhile most pharma companies have turned risky on account of regulatory clamps, investors have switched to companies with healthy pipeline a...
- Thyrocare margins likely to be hit as firm aims opening more regional labs and expand businessThe business growth is expected to come from opening of new regional laboratories, increasing the battery of preventive healthcare tests.
- Non-FDA triggers key to gradual pharma sector recoveryAfter hitting record highs on the bourses in 2015, pharma stocks have taken a beating with valuations having rationalised — coming off from...
- Mid-sized FMCG firms outperform larger peers in 2015, GCPL, Britannia most promisingThe year 2015 proved good for midsized FMCG companies like Britannia, Marico, Emami and Dabur, as compared to their larger peers.
- Strong growth and fair valuation make Alkem Labs a good betMumbaibased Alkem Labs is the local market leader in anti-infectives. It earns three-fourths of its revenues from India – a significant por...
- Why has no Godrej company been part of top indices?Godrej Industries is trading at a relative discount to its subsidiaries. GCPL is the group company with the largest M-cap.
- Real estate stocks: Is it time to play contrarian?Most realty companies are saddled with debts and unsold apartments while stock prices are near or even below listing prices.
- HUL pegged to grow at 5-6 per cent ; net sales to be around Rs 7,489 crore for September quarterThe consumer demand environment has not fully revived for the company to report a better growth in volumes than in the June quarter.
- Not just MNCs, local cash-rich pharma companies also take to deal streetMultinational firms have been usually acquiring Indian drugmakers to expand in the country and leverage their manufacturing facilities.
- Sun Pharma tops domestic drugmakers' list; Cipla and Ranbaxy slip two positions eachMumbai-based Sun Pharma has made it to the top of the domestic drug makers’ leaderboard through overseas acquisitions and quadrupling of re...
- Heard on the Street: Reliance, HSBCStock traders, who were gearing up for a subdued close on Friday, were caught by surprise in the last hour of trading after benchmark indic...
Load More
